Richard Payerchin is editor of Medical Economics.
Bipartisan group brings back prior authorization reform legislation in Congress
HHS has made changes, but lawmakers want prior auth procedures codified in law.
Former President Joe Biden’s cancer diagnosis: What we know so far, and treatment options
Biden reveals aggressive prostate cancer that has metastasized to his bones.
Trump, HHS take aim at drug prices with policies affecting Big Pharma, ending ‘global free-riding’
HHS announces plan to create ‘most-favored-nation’ cost scale so U.S. is not subsidizing drug prices in other countries.
Compounded GLP-1 RA drugs: Getting to know about pharmacy compounding
APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.
Compounded GLP-1 RA drugs: Advice to physicians and other prescribers
Compounded GLP-1 RA drugs: What about prices? Are compounded drugs cheaper or more expensive than manufacturers’ versions?
Biden prostate cancer diagnosis: A physician expert offers his first impressions
The former president likely will have drug therapy to lower his testosterone levels, but there are other treatment options.
Compounded GLP-1 RA drugs: Can pharmacists make drugs that are essentially a copy of another drug? Part 2
Biden prostate cancer diagnosis: The newest developments for doctors
Daniel Isaac, DO, MS, an oncologist/hematologist, discusses the publicly disclosed diagnosis of prostate cancer in former President Joe Biden.
Biden prostate cancer diagnosis: The importance of primary care and cancer detection
Biden prostate cancer diagnosis: Surgerical options, and discovering the disease
Biden prostate cancer diagnosis: Treatment options
Biden prostate cancer diagnosis: What we know so far
Compounded GLP-1 RA drugs: GLP-1 RA drugs are no longer in shortage, but compounding customized versions of them may continue, part 1
Compounded GLP-1 RA drugs: A continuing discussion about GLP-1 RA drugs, the perfect storm of demand and shortages, part 2
Compounded GLP-1 RA drugs: Are GLP-1 RA drugs the biggest phenomenon in American health care? Part 1
Compounded GLP-1 RA drugs: Criteria for compounding medicines to fill gaps that drugmakers can’t fill
Compounded GLP-1 RA drugs: An introduction to the Alliance for Pharmacy Compounding
Medicaid spending, effects on health care at heart of federal budget debate
House Budget Committee takes up debate and AMGA publishes projections due to Medicaid cuts in One Big Beautiful Bill Act.
Opioid deaths decline, but advocates say crisis progress is at risk from lower federal spending
Trump administration tallies ‘staggering cost’ of opioid epidemic as lawmakers ponder budget.
Physician lawmakers take part in examining Kennedy and HHS 2026 budget
Congressional committees review spending with Health and Human Services Department leader.
‘Primary care is the answer’ to Make America Healthy Again
Public health experts react to HHS Secretary Robert F. Kennedy’s testimony of budget in House of Representatives.
HHS Secretary RFK Jr. touts primary care, agency reforms and restructuring to Make America Healthy Again
Robert F. Kennedy Jr. testifies about HHS budget before House Appropriations Committee.
Doctors in Congress tout reforms, potential problems in federal Medicaid spending
House committee begins deliberations on federal budget reconciliation bill, which includes Medicaid.
Federal budget will bolster Medicaid for those who need it, stop abuses of those who don’t, House leader says
Energy & Commerce Chair Rep. Brett Guthrie spells out need for changes to Medicaid.
Medicaid cuts: Democrats pan Republican plan to change major payer in U.S. health care
Three House committee leaders speak out on spending plan up for debate today.
Potential Medicaid cuts spark debate over health care in federal budget
Republican committee chair says Medicaid claims are unfounded, but advocacy groups, Democrats are predicting dire consequences.
Embracing MAHA: Can physicians and other clinicians find advantages in movement to Make America Healthy Again?
Panel discusses need for communication and importance of primary care in relation to oncology and cancer treatments.
FDA, NIH announce food safety collaboration as FDA gives nod to 3 new natural food colorings
Ultraprocessed foods, oil-based dyes are FDA targets as part of Make America Healthy Again initiative.
Physician pay, HHS leadership, maternal health: a Senate roundup
Make America Healthy Again, HHS all on the agenda this week in U.S. Senate.